Abstract
The advent of post genomic technologies and their application to biomedical problems resulted in a massive increase the complexity of data generated. This has resulted in the need for more refined statistical and computational methods for analysis of this type of data Through comprehensive analysis and modelling approaches, structures or classes in the data can be defined, denovo predictive biomarkers identified and clinical decision support systems developed. This review seeks to provide an overview of some of the computational methodologies that have been used for data-mining complex high throughput data for the identification of new biomarkers or improvement of existing biomarkers. Given the literature is vast within the area of computational algorithms we seek to present commonly used methods.
Keywords: Biomarkers, ANN, SVM, logistic regression
Current Cancer Therapy Reviews
Title: Computational & Statistical Methodologies to Identify Biomarkers in Cancer
Volume: 4 Issue: 2
Author(s): Graham R. Ball
Affiliation:
Keywords: Biomarkers, ANN, SVM, logistic regression
Abstract: The advent of post genomic technologies and their application to biomedical problems resulted in a massive increase the complexity of data generated. This has resulted in the need for more refined statistical and computational methods for analysis of this type of data Through comprehensive analysis and modelling approaches, structures or classes in the data can be defined, denovo predictive biomarkers identified and clinical decision support systems developed. This review seeks to provide an overview of some of the computational methodologies that have been used for data-mining complex high throughput data for the identification of new biomarkers or improvement of existing biomarkers. Given the literature is vast within the area of computational algorithms we seek to present commonly used methods.
Export Options
About this article
Cite this article as:
Ball R. Graham, Computational & Statistical Methodologies to Identify Biomarkers in Cancer, Current Cancer Therapy Reviews 2008; 4 (2) . https://dx.doi.org/10.2174/157339408784310043
DOI https://dx.doi.org/10.2174/157339408784310043 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Tumoural Expression of Connective Tissue Growth Factor (CTGF) Impacts on Survival in Patients Diagnosed with Hepatocellular Carcinoma (HCC)
Current Cancer Drug Targets Molecular Imaging of Apoptosis with Radio-Labeled Annexin A5 Focused on the Evaluation of Tumor Response to Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Intercalation of Erlotinib and Pemetrexed in the Treatment of Non-Small Cell Lung Cancer
Current Drug Targets Carbohydrate-Dependent Defense Mechanisms Against Helicobacter pylori Infection
Current Drug Metabolism Unraveling Potential Candidate Targets Associated with Expression of p16<sup>INK4a</sup> or p16 Truncated Fragment by Comparative Proteomics Analysis
Current Proteomics A Structure-Function Perspective of Jak2 Mutations and Implications for Alternate Drug Design Strategies: The Road not Taken
Current Medicinal Chemistry Hypoxic Tumor Microenvironment and Cancer Cell Differentiation
Current Molecular Medicine Subungueal Haemorrhages Following Docetaxel (Taxotere) Treatment
Current Drug Safety Green Chemistry Approach as a Versatile Platform for Nanoparticles with Biomedical Applications
Nanoscience & Nanotechnology-Asia Plant Polyphenols and Oral Health: Old Phytochemicals for New Fields
Current Medicinal Chemistry The Mechanisms of Anticancer Agents by Genistein and Synthetic Derivatives of Isoflavone
Mini-Reviews in Medicinal Chemistry Radiopharmaceuticals in Tumor Hypoxia Imaging: A Review Focused on Medicinal Chemistry Aspects
Anti-Cancer Agents in Medicinal Chemistry Topical Use of Sucralfate in Epithelial Wound Healing: Clinical Evidence and Molecular Mechanisms of Action
Recent Patents on Inflammation & Allergy Drug Discovery Radiopharmaceutical: Revolutionary Agents for Diagnosis
Current Radiopharmaceuticals Potential Targets for Improving Radiosensitivity of Breast Tumor-Initiating Cells
Anti-Cancer Agents in Medicinal Chemistry dUTPase in Human Neoplastic Cells as a Potential Target for Therapeutic Intervention
Current Protein & Peptide Science Antiproliferative and Proapoptotic Effects of Proteasome Inhibitors and their Combination with Histone Deacetylase Inhibitors on Leukemia Cells
Cardiovascular & Hematological Disorders-Drug Targets Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery Computational Evaluation and In Vitro Validation of New Epidermal Growth Factor Receptor Inhibitors
Current Topics in Medicinal Chemistry Important Anti-Cancer Applications of Protein Based Nanoparticles
Current Proteomics